Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer

OBJECTIVE: To assess the efficacy and safety of cetuximab (CE) versus bevacizumab (BE) maintenance treatment after prior 8-cycle modified 5-fluorouracil, folinate, oxaliplatin, and irinotecan (FOLFOXIRI) plus CE induction therapy in treatment-naive KRAS and BRAF wild-type (wt) metastatic colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Baomin, Zheng, Donghua, Yu, Weiguang, Huang, Cuiping, Ye, Junxing, Han, Guowei, Zhuang, Jintao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545770/
https://www.ncbi.nlm.nih.gov/pubmed/32993393
http://dx.doi.org/10.1177/0300060520930440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545770/
https://www.ncbi.nlm.nih.gov/pubmed/32993393
http://dx.doi.org/10.1177/0300060520930440

Ejemplares similares